{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T14:47:39Z","timestamp":1769438859196,"version":"3.49.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T00:00:00Z","timestamp":1659571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T00:00:00Z","timestamp":1659571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["19ek0109295H0003"],"award-info":[{"award-number":["19ek0109295H0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18K08281"],"award-info":[{"award-number":["18K08281"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020377","name":"Maruho Takagi Dermatology Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100020377","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Loss-of-function homozygous or compound heterozygous mutations in <jats:italic>IL36RN<\/jats:italic>, which encodes interleukin-36 receptor antagonist (IL-36Ra), have been implicated in the pathogenesis of skin disorders. We previously reported that <jats:italic>Il36rn<\/jats:italic><jats:sup><jats:italic>\u2212\/\u2212<\/jats:italic><\/jats:sup> mice exhibit an enhanced contact hypersensitivity (CHS) response through increased neutrophil recruitment. In addition, <jats:italic>Il36rn<\/jats:italic><jats:sup><jats:italic>\u2212\/\u2212<\/jats:italic><\/jats:sup> mice show severe imiquimod-induced psoriatic skin lesions and enhanced neutrophil extracellular trap (NET) formation. We hypothesized that NETs may play an important role in the CHS response. To confirm this, we examined the CHS response and NET formation in <jats:italic>Il36rn<\/jats:italic><jats:sup><jats:italic>\u2212\/\u2212<\/jats:italic><\/jats:sup> mice. <jats:italic>Il36rn<\/jats:italic><jats:sup><jats:italic>\u2212\/\u2212<\/jats:italic><\/jats:sup> mice showed enhanced CHS responses, increased infiltration of inflammatory cells, including neutrophils, CD4<jats:sup>+<\/jats:sup> T cells, and CD8<jats:sup>+<\/jats:sup> T cells, NET formation, and enhanced mRNA expression of cytokines and chemokines, including IL-1\u03b2, C-X-C motif chemokine ligand (CXCL)1, CXCL2, and IL-36\u03b3. Furthermore, NET formation blockade improved the CHS response, which consequently decreased inflammatory cell infiltration and NET formation. Consistently, we observed decreased expression of these cytokines and chemokines. These findings indicate that IL-36Ra deficiency aggravates the CHS response caused by excessive inflammatory cell recruitment, NET formation, and cytokine and chemokine production, and that NET formation blockade alleviates the CHS response. Thus, NET formation may play a prominent role in the CHS response.<\/jats:p>","DOI":"10.1038\/s41598-022-16449-z","type":"journal-article","created":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T09:02:55Z","timestamp":1659603775000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Neutrophil extracellular traps are involved in enhanced contact hypersensitivity response in IL-36 receptor antagonist-deficient mice"],"prefix":"10.1038","volume":"12","author":[{"given":"Yurie","family":"Hasegawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidehiko","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihito","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soichiro","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenta","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mizuki","family":"Sugiura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumitsu","family":"Sugiura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,4]]},"reference":[{"key":"16449_CR1","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/ni1110-973","volume":"11","author":"C Dinarello","year":"2010","unstructured":"Dinarello, C. et al. IL-1 family nomenclature. Nat. Immunol. 11, 973. https:\/\/doi.org\/10.1038\/ni1110-973 (2010).","journal-title":"Nat. Immunol."},{"key":"16449_CR2","doi-asserted-by":"publisher","first-page":"13677","DOI":"10.1074\/jbc.M400117200","volume":"279","author":"JE Towne","year":"2004","unstructured":"Towne, J. E., Garka, K. E., Renshaw, B. R., Virca, G. D. & Sims, J. E. Interleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-kappaB and MAPKs. J. Biol. Chem. 279, 13677\u201313688. https:\/\/doi.org\/10.1074\/jbc.M400117200 (2004).","journal-title":"J. Biol. Chem."},{"key":"16449_CR3","doi-asserted-by":"publisher","first-page":"6053","DOI":"10.4049\/jimmunol.1301481","volume":"192","author":"AM Foster","year":"2014","unstructured":"Foster, A. M. et al. IL-36 promotes myeloid cell infiltration, activation, and inflammatory activity in skin. J. Immunol. 192, 6053\u20136061. https:\/\/doi.org\/10.4049\/jimmunol.1301481 (2014).","journal-title":"J. Immunol."},{"key":"16449_CR4","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.jid.2016.04.038","volume":"136","author":"M Tauber","year":"2016","unstructured":"Tauber, M. et al. IL36RN mutations affect protein expression and function: A basis for genotype-phenotype correlation in pustular diseases. J. Investig. Dermatol. 136, 1811\u20131819. https:\/\/doi.org\/10.1016\/j.jid.2016.04.038 (2016).","journal-title":"J. Investig. Dermatol."},{"key":"16449_CR5","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1056\/NEJMoa1013068","volume":"365","author":"S Marrakchi","year":"2011","unstructured":"Marrakchi, S. et al. Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N. Engl. J. Med. 365, 620\u2013628. https:\/\/doi.org\/10.1056\/NEJMoa1013068 (2011).","journal-title":"N. Engl. J. Med."},{"key":"16449_CR6","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.ajhg.2011.07.022","volume":"89","author":"A Onoufriadis","year":"2011","unstructured":"Onoufriadis, A. et al. Mutations in IL36RN\/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis. Am. J. Hum. Genet. 89, 432\u2013437. https:\/\/doi.org\/10.1016\/j.ajhg.2011.07.022 (2011).","journal-title":"Am. J. Hum. Genet."},{"key":"16449_CR7","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.4049\/jimmunol.167.3.1440","volume":"167","author":"R Debets","year":"2001","unstructured":"Debets, R. et al. Two novel IL-1 family members, IL-1 delta and IL-1 epsilon, function as an antagonist and agonist of NF-kappa B activation through the orphan IL-1 receptor-related protein 2. J. Immunol. 167, 1440\u20131446. https:\/\/doi.org\/10.4049\/jimmunol.167.3.1440 (2001).","journal-title":"J. Immunol."},{"key":"16449_CR8","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1038\/jid.2013.230","volume":"133","author":"K Sugiura","year":"2013","unstructured":"Sugiura, K. et al. The majority of generalized pustular psoriasis without psoriasis vulgaris is caused by deficiency of interleukin-36 receptor antagonist. J. Investig. Dermatol. 133, 2514\u20132521. https:\/\/doi.org\/10.1038\/jid.2013.230 (2013).","journal-title":"J. Investig. Dermatol."},{"key":"16449_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-021-00677-8","author":"K Sugiura","year":"2022","unstructured":"Sugiura, K. Role of interleukin 36 in generalised pustular psoriasis and beyond. Dermatol. Ther. https:\/\/doi.org\/10.1007\/s13555-021-00677-8 (2022).","journal-title":"Dermatol. Ther."},{"key":"16449_CR10","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jdermsci.2018.01.012","volume":"90","author":"M Akiyama","year":"2018","unstructured":"Akiyama, M., Takeichi, T., McGrath, J. A. & Sugiura, K. Autoinflammatory keratinization diseases: An emerging concept encompassing various inflammatory keratinization disorders of the skin. J. Dermatol. Sci. 90, 105\u2013111. https:\/\/doi.org\/10.1016\/j.jdermsci.2018.01.012 (2018).","journal-title":"J. Dermatol. Sci."},{"key":"16449_CR11","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.jaci.2017.05.019","volume":"140","author":"M Akiyama","year":"2017","unstructured":"Akiyama, M., Takeichi, T., McGrath, J. A. & Sugiura, K. Autoinflammatory keratinization diseases. J. Allergy Clin. Immunol. 140, 1545\u20131547. https:\/\/doi.org\/10.1016\/j.jaci.2017.05.019 (2017).","journal-title":"J. Allergy Clin. Immunol."},{"key":"16449_CR12","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.3389\/fimmu.2020.01753","volume":"11","author":"M Akiyama","year":"2020","unstructured":"Akiyama, M., De Vita, V. & Sugiura, K. Editorial: Autoinflammatory keratinization disease (AiKD). Front. Immunol. 11, 1753. https:\/\/doi.org\/10.3389\/fimmu.2020.01753 (2020).","journal-title":"Front. Immunol."},{"key":"16449_CR13","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jdermsci.2014.02.006","volume":"74","author":"K Sugiura","year":"2014","unstructured":"Sugiura, K. The genetic background of generalized pustular psoriasis: IL36RN mutations and CARD14 gain-of-function variants. J. Dermatol. Sci. 74, 187\u2013192. https:\/\/doi.org\/10.1016\/j.jdermsci.2014.02.006 (2014).","journal-title":"J. Dermatol. Sci."},{"key":"16449_CR14","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/s41598-020-57550-5","volume":"10","author":"H Fukushima","year":"2020","unstructured":"Fukushima, H. et al. TAK-242 ameliorates contact dermatitis exacerbated by IL-36 receptor antagonist deficiency. Sci. Rep. 10, 734. https:\/\/doi.org\/10.1038\/s41598-020-57550-5 (2020).","journal-title":"Sci. Rep."},{"key":"16449_CR15","doi-asserted-by":"publisher","first-page":"20149","DOI":"10.1038\/s41598-020-76864-y","volume":"10","author":"S Watanabe","year":"2020","unstructured":"Watanabe, S. et al. Neutrophil extracellular traps are induced in a psoriasis model of interleukin-36 receptor antagonist-deficient mice. Sci. Rep. 10, 20149. https:\/\/doi.org\/10.1038\/s41598-020-76864-y (2020).","journal-title":"Sci. Rep."},{"key":"16449_CR16","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nm.4294","volume":"23","author":"SK Jorch","year":"2017","unstructured":"Jorch, S. K. & Kubes, P. An emerging role for neutrophil extracellular traps in noninfectious disease. Nat. Med. 23, 279\u2013287. https:\/\/doi.org\/10.1038\/nm.4294 (2017).","journal-title":"Nat. Med."},{"key":"16449_CR17","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1590\/abd1806-4841.20186340","volume":"93","author":"MC Silvestre","year":"2018","unstructured":"Silvestre, M. C., Sato, M. N. & Reis, V. Innate immunity and effector and regulatory mechanisms involved in allergic contact dermatitis. An. Bras. Dermatol. 93, 242\u2013250. https:\/\/doi.org\/10.1590\/abd1806-4841.20186340 (2018).","journal-title":"An. Bras. Dermatol."},{"key":"16449_CR18","doi-asserted-by":"publisher","first-page":"e0169397","DOI":"10.1371\/journal.pone.0169397","volume":"12","author":"X Jiang","year":"2017","unstructured":"Jiang, X. et al. Dermal \u03b3\u03b4 T cells do not freely re-circulate out of skin and produce IL-17 to promote neutrophil infiltration during primary contact hypersensitivity. PLoS ONE 12, e0169397. https:\/\/doi.org\/10.1371\/journal.pone.0169397 (2017).","journal-title":"PLoS ONE"},{"key":"16449_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/all.14986","author":"AB Funch","year":"2021","unstructured":"Funch, A. B. et al. CD8(+) tissue-resident memory T cells recruit neutrophils that are essential for flare-ups in contact dermatitis. Allergy https:\/\/doi.org\/10.1111\/all.14986 (2021).","journal-title":"Allergy"},{"key":"16449_CR20","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41419-018-0538-5","volume":"9","author":"L Chen","year":"2018","unstructured":"Chen, L. et al. Neutrophil extracellular traps promote macrophage pyroptosis in sepsis. Cell Death Dis. 9, 597. https:\/\/doi.org\/10.1038\/s41419-018-0538-5 (2018).","journal-title":"Cell Death Dis."},{"key":"16449_CR21","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/cei.12761","volume":"184","author":"MA Boutet","year":"2016","unstructured":"Boutet, M. A. et al. Distinct expression of interleukin (IL)-36\u03b1, \u03b2 and \u03b3, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn\u2019s disease. Clin. Exp. Immunol. 184, 159\u2013173. https:\/\/doi.org\/10.1111\/cei.12761 (2016).","journal-title":"Clin. Exp. Immunol."},{"key":"16449_CR22","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1172\/jci63451","volume":"122","author":"L Tortola","year":"2012","unstructured":"Tortola, L. et al. Psoriasiform dermatitis is driven by IL-36-mediated DC-keratinocyte crosstalk. J. Clin. Investig. 122, 3965\u20133976. https:\/\/doi.org\/10.1172\/jci63451 (2012).","journal-title":"J. Clin. Investig."},{"key":"16449_CR23","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1111\/j.1365-2133.2009.09106.x","volume":"160","author":"J Bourke","year":"2009","unstructured":"Bourke, J., Coulson, I. & English, J. Guidelines for the management of contact dermatitis: An update. Br. J. Dermatol. 160, 946\u2013954. https:\/\/doi.org\/10.1111\/j.1365-2133.2009.09106.x (2009).","journal-title":"Br. J. Dermatol."},{"key":"16449_CR24","doi-asserted-by":"publisher","first-page":"371","DOI":"10.4103\/0378-6323.178903","volume":"82","author":"AB Mehta","year":"2016","unstructured":"Mehta, A. B. et al. Topical corticosteroids in dermatology. Indian J. Dermatol. Venereol. Leprol. 82, 371\u2013378. https:\/\/doi.org\/10.4103\/0378-6323.178903 (2016).","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"16449_CR25","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/0092-8674(90)90395-u","volume":"62","author":"C Jonat","year":"1990","unstructured":"Jonat, C. et al. Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos\/Jun) activity by glucocorticoid hormone. Cell 62, 1189\u20131204. https:\/\/doi.org\/10.1016\/0092-8674(90)90395-u (1990).","journal-title":"Cell"},{"key":"16449_CR26","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/0092-8674(90)90396-v","volume":"62","author":"HF Yang-Yen","year":"1990","unstructured":"Yang-Yen, H. F. et al. Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62, 1205\u20131215. https:\/\/doi.org\/10.1016\/0092-8674(90)90396-v (1990).","journal-title":"Cell"},{"key":"16449_CR27","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/0092-8674(90)90397-w","volume":"62","author":"R Sch\u00fcle","year":"1990","unstructured":"Sch\u00fcle, R. et al. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell 62, 1217\u20131226. https:\/\/doi.org\/10.1016\/0092-8674(90)90397-w (1990).","journal-title":"Cell"},{"key":"16449_CR28","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1159\/000448808","volume":"9","author":"BM Biron","year":"2017","unstructured":"Biron, B. M. et al. Cl-amidine prevents histone 3 citrullination and neutrophil extracellular trap formation, and improves survival in a murine sepsis model. J. Innate Immun. 9, 22\u201332. https:\/\/doi.org\/10.1159\/000448808 (2017).","journal-title":"J. Innate Immun."},{"key":"16449_CR29","first-page":"506","volume":"64","author":"E Czarnobilska","year":"2007","unstructured":"Czarnobilska, E., Obtu\u0142owicz, K. & Wso\u0142ek, K. Type IV of hypersensitivity and its subtypes. Przegl. Lek. 64, 506\u2013508 (2007).","journal-title":"Przegl. Lek."},{"key":"16449_CR30","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.13499.1","author":"SF Martin","year":"2018","unstructured":"Martin, S. F., Rustemeyer, T. & Thyssen, J. P. Recent advances in understanding and managing contact dermatitis. F1000Research https:\/\/doi.org\/10.12688\/f1000research.13499.1 (2018).","journal-title":"F1000Research"},{"key":"16449_CR31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1084\/jem.20130062","volume":"212","author":"FC Weber","year":"2015","unstructured":"Weber, F. C. et al. Neutrophils are required for both the sensitization and elicitation phase of contact hypersensitivity. J. Exp. Med. 212, 15\u201322. https:\/\/doi.org\/10.1084\/jem.20130062 (2015).","journal-title":"J. Exp. Med."},{"key":"16449_CR32","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jaut.2017.01.007","volume":"80","author":"A Shibata","year":"2017","unstructured":"Shibata, A. et al. Toll-like receptor 4 antagonist TAK-242 inhibits autoinflammatory symptoms in DITRA. J. Autoimmun. 80, 28\u201338. https:\/\/doi.org\/10.1016\/j.jaut.2017.01.007 (2017).","journal-title":"J. Autoimmun."},{"key":"16449_CR33","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.4049\/jimmunol.1100928","volume":"188","author":"DD Kish","year":"2012","unstructured":"Kish, D. D., Gorbachev, A. V. & Fairchild, R. L. IL-1 receptor signaling is required at multiple stages of sensitization and elicitation of the contact hypersensitivity response. J. Immunol. 188, 1761\u20131771. https:\/\/doi.org\/10.4049\/jimmunol.1100928 (2012).","journal-title":"J. Immunol."},{"key":"16449_CR34","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671\u2013675. https:\/\/doi.org\/10.1038\/nmeth.2089 (2012).","journal-title":"Nat. Methods"},{"key":"16449_CR35","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/jdv.17767","volume":"36","author":"Y Tanaka","year":"2022","unstructured":"Tanaka, Y. et al. Cutaneous ischemia-reperfusion injury is exacerbated by IL-36 receptor antagonist deficiency. J. Eur. Acad. Dermatol. Venereol. 36, 295\u2013304. https:\/\/doi.org\/10.1111\/jdv.17767 (2022).","journal-title":"J. Eur. Acad. Dermatol. Venereol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-16449-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-16449-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-16449-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T05:09:59Z","timestamp":1669352999000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-16449-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,4]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["16449"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-16449-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,4]]},"assertion":[{"value":"9 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13384"}}